Treatment Patterns and Outcomes Among Elderly Glioblastoma Patients in Riyadh, Saudi Arabia

References

• Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 2012;14(Suppl 5):v1–v49. doi:10.1093/neuonc/nos218
   PubMed Web of Science ®Google Scholar
• Chakrabarti I, Cockburn M, Cozen W, et al. A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer. 2005;104(12):2798–2806. doi:10.1002/cncr.21539
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996. PMID: 15758009. doi:10.1056/NEJMoa043330
   PubMed Web of Science ®Google Scholar
• Iwamoto FM, Reiner AS, Panageas KS, et al. Patterns of care in elderly glioblastoma patients. Ann Neurol. 2008;64(6):628–634. doi:10.1002/ana.21521
   PubMed Web of Science ®Google Scholar
• Barnholtz-Sloan JS, Maldonado JL, Williams VL, et al. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol. 2007;85(2):171–180. doi:10.1007/s11060-007-9405-4
   PubMed Web of Science ®Google Scholar
• Walker GV, Li J, Mahajan A, et al. Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme. Cancer. 2012;118(18):4538–4544. doi:10.1002/cncr.27439
   PubMed Web of Science ®Google Scholar
• Scott J, Tsai YY, Chinnaiyan P, et al. Effectiveness of radiotherapy for elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys. 2011;81(1):206–210. doi:10.1016/j.ijrobp.2010.04.033
   PubMed Web of Science ®Google Scholar
• Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356(15):1527–1535. doi:10.1056/NEJMoa065901
   PubMed Web of Science ®Google Scholar
• Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22(9):1583–1588. doi:10.1200/JCO.2004.06.082
   PubMed Web of Science ®Google Scholar
• Malmström A, Grønberg BH, Marosi C, et al.; Nordic Clinical Brain Tumour Study Group (NCBTSG). Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, Phase 3 trial. Lancet Oncol. 2012;13(9):916–926. PMID: 22877848. doi:10.1016/S1470-2045(12)70265-6
   PubMed Web of Science ®Google Scholar
• Wick W, Platten M, Meisner C, et al.; NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13(7):707–715. PMID: 22578793. doi:10.1016/S1470-2045(12)70164-X
   PubMed Web of Science ®Google Scholar
• Perry JR, Laperriere N, O’Callaghan CJ, et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 2017;376:1027–1037. doi:10.1056/NEJMoa1611977
   PubMed Web of Science ®Google Scholar
• Scoccianti S, Magrini SM, Ricardi U, et al. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology). Neurosurgery. 2010;67:446–458. doi:10.1227/01.NEU.0000371990.86656.E8
   PubMed Web of Science ®Google Scholar
• Ewelt C, Goeppert M, Rapp M, et al. Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol. 2011;103:611–618. doi:10.1007/s11060-010-0429-9
   PubMed Web of Science ®Google Scholar
• Burton E, Ugiliweneza B, Woo S, Skirboll S, Boaky M, Surveillance A. Epidemiology and end results–medicare data analysis of elderly patients with glioblastoma multiforme: treatment patterns, outcomes and cost. Mol Clin Oncol. 2015;3:971–978. doi:10.3892/mco.2015.590
   PubMed Web of Science ®Google Scholar
• Li SW, Qiu XG, Chen BS, et al. Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J (Engl). 2009;122:1245–1249.
   PubMed Web of Science ®Google Scholar
• Tait MJ, Petrik V, Loosemore A, et al. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg. 2007;21:496–500. doi:10.1080/02688690701449251
   PubMed Web of Science ®Google Scholar
• Tugcu B, Postalci LS, Gunaldi O, et al. Efficacy of clinical prognostic factors on survival in patients with glioblastoma. Turk Neurosurg. 2010;20:117–125. doi:10.5137/1019-5149.JTN.2461-09.4
   PubMed Web of Science ®Google Scholar
• Cheng H-B, Yue W, Xie C, Zhang R-Y, Hu -S-S, Wang Z. IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis. Tumour Biol. 2013;34(6):3555–3559. doi:10.1007/s13277-013-0934-5
   PubMedGoogle Scholar
• Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J. debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien). 2003;145:5–10. doi:10.1007/s00701-002-1030-6
   PubMed Web of Science ®Google Scholar
• Seiz M, Krafft U, Freyschlag CF, et al. Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution. J Cancer Res Clin Oncol. 2010;136(11):1691–1695. doi:10.1007/s00432-010-0827-6
   PubMed Web of Science ®Google Scholar
• Malkoun N, Chargari C, Forest F, et al. Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression. J Neurooncol. 2012;106(1):127–133. doi:10.1007/s11060-011-0643-0
   PubMed Web of Science ®Google Scholar
• Minniti G, Scaringi C, Lanzetta G, et al. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol Biol Phys. 2015;91:109–115. doi:10.1016/j.ijrobp.2014.09.013
   PubMed Web of Science ®Google Scholar